James L. Tyree - Dec 17, 2021 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role
Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Stock symbol
CCXI
Transactions as of
Dec 17, 2021
Transactions value $
-$817,415
Form type
4
Date filed
12/21/2021, 05:33 PM
Previous filing
May 24, 2021
Next filing
May 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Options Exercise $316K +25K +163.67% $12.62 40.3K Dec 17, 2021 Direct
transaction CCXI Common Stock Options Exercise $180K +12.5K +31.04% $14.42 52.8K Dec 17, 2021 Direct
transaction CCXI Common Stock Sale -$93.9K -2.8K -5.31% $33.52 50K Dec 17, 2021 Direct F1, F2
transaction CCXI Common Stock Sale -$578K -16.6K -33.28% $34.74 33.3K Dec 17, 2021 Direct F1, F3
transaction CCXI Common Stock Sale -$641K -18.1K -54.19% $35.50 15.3K Dec 17, 2021 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Stock Option (right to buy) Options Exercise -25K -100% 0 Dec 17, 2021 Common Stock 25K $12.62 Direct F5, F6
transaction CCXI Stock Option (right to buy) Options Exercise -12.5K -100% 0 Dec 17, 2021 Common Stock 12.5K $14.42 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $33.14 to $34.09 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F3 Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $34.15 to $35.14 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F4 Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $35.15 to $35.90 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F5 As of December 17, 2021, and prior to this transaction, the exercised options were fully vested.
F6 Not applicable.